These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23085648)

  • 1. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
    Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
    J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
    Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
    Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on hepatic iron overload in chronic hepatitis C patients].
    Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
    Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt.
    el-Shorbagy E; Afefy AF; Ibrahem IA; Mangoud AM; Eissa MH; Sabee EI; Mahrous S; Abdel-Monem A; Ismail A; Morsy TA; Etewa S; Nor Edin E; Mostafa Y; Abouel-Magd Y; el-Sedawy M; Ragab H; el-Tokhy H; Hassan MI; Lakouz K; Abdel-Aziz K; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):459-78. PubMed ID: 15124753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.
    Petta S; Grimaudo S; Tripodo C; Cabibi D; Calvaruso M; Di Cristina A; Guarnotta C; Macaluso FS; Minissale MG; Marchesini G; Craxì A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):193-200. PubMed ID: 25268393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
    Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
    J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
    Maylin S; Laouénan C; Martinot-Peignoux M; Panhard X; Lapalus M; Nicolas-Chanoine MH; Bedossa P; Asselah T; Marcellin P
    J Clin Virol; 2012 Jan; 53(1):43-7. PubMed ID: 22099210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
    Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
    Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
    Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.
    Berres ML; Schlosser B; Berg T; Trautwein C; Wasmuth HE
    J Clin Gastroenterol; 2012 Apr; 46(4):334-8. PubMed ID: 21934527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
    Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.